Biggest News Aggregation in the World
๐Ÿ“ฐ Johnm Leonard News

Johnm Leonard News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Johnm Leonard. Real-time updates on events, politics, business and more.

Intellia Therapeutics (NASDAQ:NTLA) Shares Up 11.3%

Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report)’s stock price traded up 11.3% during trading on Tuesday . The company traded as high as $31.13 and last traded at $30.79. 2,174,127 shares changed hands during trading, an increase of 39% from the average session volume of 1,563,047 shares. The stock had previously closed at $27.66. […]
Johnm Leonard David Lebwohl Morgan Stanley Group Wealth Management Penserra Capital Management Intellia Therapeutics Inc

Intellia Therapeutics (NASDAQ:NTLA) Releases Earnings Results, Beats Expectations By $0.01 EPS

Intellia Therapeutics (NASDAQ:NTLA – Get Free Report) issued its earnings results on Thursday. The company reported ($1.46) earnings per share for the quarter, topping the consensus estimate of ($1.47) by $0.01, Briefing.com reports. Intellia Therapeutics had a negative return on equity of 43.31% and a negative net margin of 893.34%. The business had revenue of […]
Nova Scotia David Lebwohl Johnm Leonard Vanguard Group Inc Intellia Therapeutics Inc Royal Bank

Intellia Therapeutics (NASDAQ:NTLA) Announces Earnings Results

Intellia Therapeutics (NASDAQ:NTLA – Get Free Report) posted its earnings results on Thursday. The company reported ($1.46) EPS for the quarter, topping the consensus estimate of ($1.47) by $0.01, Briefing.com reports. Intellia Therapeutics had a negative net margin of 893.34% and a negative return on equity of 40.49%. The firm had revenue of ($1.92) million […]
Hong Kong David Lebwohl Johnm Leonard Hong Kong Ltd Wolfe Research Group Wealth Management

Aigen Investment Management LP Takes Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)

Aigen Investment Management LP purchased a new stake in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 17,569 shares of the company’s stock, valued at approximately $556,000. Other institutional investors have also made changes to […]
Glenn Goddard Johnm Leonard Dekabank Deutsche Girozentrale Securities Exchange Commission Intellia Therapeutics Inc Envestnet Asset Management Inc

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Receives $75.47 Consensus Target Price from Brokerages

Shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report) have earned an average rating of “Moderate Buy” from the eighteen research firms that are presently covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and fifteen have assigned a buy recommendation to the company. The average twelve-month […]
Raymond James Johnm Leonard David Lebwohl Securities Exchange Commission Goldman Sachs Group Intellia Therapeutics Company Profile
Source: wkrb13.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Brokerages Set Intellia Therapeutics, Inc. (NASDAQ:NTLA) Price Target at $75.47

Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report) has earned an average rating of “Moderate Buy” from the eighteen brokerages that are presently covering the stock, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. The average 12 month price objective […]
Johnm Leonard Glenn Goddard Raymond James Intellia Therapeutics Inc Blue Trust Inc Group Wealth Management

FY2025 Earnings Estimate for Intellia Therapeutics, Inc. Issued By Brookline Capital Management (NASDAQ:NTLA)

Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) – Equities researchers at Brookline Capital Management raised their FY2025 earnings per share estimates for shares of Intellia Therapeutics in a research report issued on Sunday, January 7th. Brookline Capital Management analyst L. Cann now forecasts that the company will post earnings of ($5.12) per share for the […]
Raymond James David Lebwohl Johnm Leonard Goldman Sachs Group Morgan Stanley Blair William Co

Letters: Why portrait of Noel Browne in Leinster House would be a fitting tribute

I agree with John M Leonard that the portrait of Dr Noel Browne should be on display in Leinster House (โ€˜Ballaghโ€™s portrait of Dr Browne deserves pride of place in Leinster Houseโ€™, Letters, August 4). Watching the recent documentary on the man, it seems clear he was at times hung out to dry by the establishment of the time.
Johnm Leonard Noel Browne Leinster House Leinster House Rt 201 Dublin Airport

Intellia Therapeutics, Inc. Expected to Earn Q1 2023 Earnings of ($1.42) Per Share (NASDAQ:NTLA)

Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Rating) – Analysts at William Blair issued their Q1 2023 EPS estimates for shares of Intellia Therapeutics in a research report issued to clients and investors on Wednesday, March 22nd. William Blair analyst M. Minter forecasts that the company will post earnings of ($1.42) per share for the quarter. […]
Glenn Goddard Robertw Baird Raymond James William Blair Johnm Leonard Intellia Therapeutics Company Profile
Source: wkrb13.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science